# ETOPOPHOS

NDC: 61269-410
Generic name: etoposide phosphate
Labeler / Manufacturer: H2-Pharma, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20090601

FDA application: NDA020457

## Active ingredients

- ETOPOSIDE PHOSPHATE: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61269-410"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61269-410
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7499fc35-fae8-44ad-bbab-9a1a589bf3ee